All the included trials were small and under-powered. The reporting of the trials was inadequate and as a result, risk of bias assessment was judged to be unclear for the majority of the domains in two out of the three trials. There was insufficient evidence to indicate that (i) there was a lower incidence of symptomatic UTI in people whose catheter was changed both monthly and when clinically indicated (risk ratio (RR) 0.35, 95% confidence interval (CI) 0.13 to 0.95; very low quality evidence) compared to only when clinically indicated, (ii) there was not enough evidence to assess the effect of antibiotic prophylaxis on reducing: positive urine cultures at 7 days (RR 0.91, 95% CI 0.79 to 1.04); infection (RR 1.41, 95% CI 0.55 to 3.65); or death (RR 2.12, 95% CI 0.20 to 22.30; very low quality evidence), (iii) there was no statistically significant difference in the incidence of asymptomatic bacteruria at 7 days (RR 0.80, 95% CI 0.42 to 1.52) between people receiving water or chlorhexidine solution for periurethral cleansing at the time of catheter replacement. However, none of the 16 participants developed a symptomatic catheter-associated urinary tract infection (CAUTI) at day 14.
The following outcomes were considered critical for decision-making and were also selected for the 'Summary of findings' table: (i) participant satisfaction, (ii) condition-specific quality of life, (iii) urinary tract trauma, and (iv) formal economic analysis. However, none of the trials reported these outcomes.
None of the trials compared the following comparisons: (i) replacing catheter versus other policy e.g. washouts, (ii) replacing in the home environment versus clinical environment, (iii) clean versus aseptic technique for replacing catheter, (iv) lubricant A versus lubricant B or no lubricant, and (v) catheter user versus carer versus health professional performing the catheter replacement procedure.
Authors' conclusions
There is currently insufficient evidence to assess the value of different policies for replacing long-term urinary catheters on patient outcomes. In particular, there are a number of policies for which there are currently no trial data; and a number of important outcomes which have not been assessed, including patient satisfaction, quality of life, urinary tract trauma, and economic outcomes. There is an immediate need for rigorous, adequately powered randomised controlled trials which assess important clinical outcomes and abide by the principles and recommendations of the CONSORT statement.
P L A I N L A N G U A G E S U M M A R Y

Policies for replacing long-term indwelling urinary catheters in adults
Background information
A urinary catheter is a tube that is inserted into the bladder from the end of the urethra to drain urine from the bladder. Usually, urinary catheters are only required for a few days, such as after an operation. However, there are some medical conditions that may require bladder drainage on a long-term basis. There are many different ways to care for and maintain a long-term urinary catheter. In this review we refer to these different care methods as health-care 'policies'. Examples of policies that relate to the replacement of a long-term catheter include: time between catheter replacements; use of antibiotics during replacement; use of cleaning solutions or lubricants during replacement; and personnel, environment and techniques used at replacement. This review aimed to identify which policies at the time of long-term catheter replacement were most effective in improving patient care.
The main findings of the review
This review identified that there is currently insufficient high-quality evidence which evaluates the effectiveness of different policies for replacing long-term urinary catheters. Only three randomised clinical trials, which included a total of 107 participants, were eligible and included in this review. These trials evaluated: (i) different time intervals for catheter replacement, (ii) the use of antibiotics to prevent infection and (iii) the use of different cleaning solutions. There was insufficient evidence to suggest that replacing the catheter monthly and when there was a clinical reason to do so reduced bacteria in the urine compared to replacing the catheter only when there was a clinical reason to do so. However, there was not enough evidence to say whether using antibiotics at the time of replacing the catheter for prevention of infection was effective or whether using water to cleanse during catheter replacement was as effective as an anti-bacterial washing solution.
Adverse effects
None of the trials reported any adverse effects relating to the policies investigated. 
Any limitations of the review
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation
Description of the intervention
A number of different policies can be employed during the time of catheter replacement. These policies are described below.
Time between replacements
The recommended time between catheter replacement depends on local policies and varies significantly between centres (Palka 2014; Willson 2009). This discrepancy in clinical practice reflects a lack of evidence to support the early or late replacement of long-term urinary catheters in the reduction of adverse outcomes. The Infectious Diseases Society of America (IDSA) states there is currently insufficient data to recommend a specific time interval between long-term catheter or suprapubic catheter replacement (Hooton 2010). A shorter time interval between catheter replacements may reduce the development of a biofilm that can act to harbour bacteria, and may also reduce the likelihood of mechanical blockage.
However, the tissue disruption caused by more frequent catheter replacement could contribute to the development of CAUTI and other adverse outcomes.
Antibiotics as prophylaxis
For people requiring a long-term indwelling catheter, antibiotics may be given prophylactically in an attempt to prevent CAUTI development or at the time of developing the symptoms associated with CAUTI. However, prophylactic antibiotics have been shown to permit the development of resistant organisms (Hooton 2010). A comparison of prophylactic, clinically indicated and microbiologically indicated antibiotics has been previously explored in another Cochrane Review (Lusardi 2013) . This concluded that data was limited and that there was insufficient evidence to determine best practice. 
Catheter replacement environments, personnel and techniques
Cleaning solutions
There are various cleaning solutions which can be used when replacing catheters, including sterile water, chlorhexidine gluconate and povidone-iodine. The cleaning procedure may include cleaning the perineal area as well as the periurethral area. Catheters may also be cleaned instead of replaced. Washout policies for catheters have been evaluated by a previous Cochrane review (Hagen 2010). The review indicated that "the evidence was too scanty to conclude whether or not washouts were beneficial".
Lubricants
Lubricants are commonly used in most types of urethral catheterisation to allow for easier insertion and patient comfort and typically contain local anaesthetic and antiseptic. The administration of lubricants can be incorporated into either a clean or an aseptic catheterisation technique.
Other catheter reviews
This review is one of a series of Cochrane Reviews addressing different issues in the use of catheters for long-term management of catheter users for a variety of conditions. These include:
• Washout policies in long-term indwelling urinary catheterisation in adults (Hagen 2010)
• Types of indwelling urinary catheters for long-term bladder drainage in adults (Jahn 2007)
• Long-term bladder management by intermittent catheterisation in adults and children (Moore 2007) • Urinary catheter policies for long-term bladder drainage (Niël-Weise 2005).
Why it is important to do this review
Long-term indwelling urinary catheters are used commonly in health care. Guidelines and protocols exist worldwide but are not supported by extensive or high-quality evidence. It is important that policies for replacing long-term indwelling urinary catheters are updated based on all of the existing high-quality evidence. There is an immediate need to improve the rates of adverse effects and optimise patient quality of life, patient and carer satisfaction and resource management associated with long-term catheter use. The review will also identify the specific needs for future research in this area.
O B J E C T I V E S
To determine the effectiveness of different policies for replacing long-term indwelling urinary catheters in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) or quasi-RCTs.
Types of participants
Adults (over the age of 18 years) with long-term (> 14 days) indwelling urinary or suprapubic catheters that are anticipated to require replacement.
Types of interventions
The following types of interventions were compared with each other:
1 
Other outcomes
Any other outcomes considered to be important if reported in trials.
Search methods for identification of studies
We did not impose any restrictions, for example language or publication status, on the searches described below. 
Electronic searches
Searching other resources
We searched the reference lists of relevant articles.
Data collection and analysis
Selection of studies
We included only randomised and quasi-randomised controlled trials. At least two review authors independently screened the list of titles and abstracts generated by our search. We retrieved fulltext articles of potentially relevant studies. At least two review authors independently assessed the full-text articles for eligibility. We contacted study investigators for additional information when required. We resolved any differences of opinion by discussion or involvement of a third party. We listed studies formally considered for the review that were subsequently excluded along with the reasons for their exclusion.
Data extraction and management
Two of the review authors independently extracted data of the included studies by using a standardised form. Any disagreement was resolved by discussion or by consulting a third party. We contacted study authors when there was insufficient information regarding the primary outcome in the published reports or when additional information was required. We used Review Manager software (RevMan 5.3) for data entry. We processed the included trial data according to the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011).
Assessment of risk of bias in included studies
We assessed the risk of bias in the included studies using the Cochrane 'Risk of bias' assessment tool (Higgins 2011). This included assessment of:
• sequence generation • allocation concealment • blinding of participants or therapists • blinding of outcome assessors • completeness of outcome data • selective outcome reporting • other potential sources of bias Two of the review authors independently assessed these domains and rated each as 'high risk', 'low risk' or 'unclear risk'. We resolved any differences of opinion by consensus or by consulting a third party.
Measures of treatment effect
We based analysis on available data from all included trials relevant to the comparisons and outcomes of interest. For trials with multiple publications, only the most up-to-date or complete data for each outcome were included. For categorical outcomes we related the numbers reporting an outcome to the numbers at risk in each group to calculate a risk ratio (RR) with 95% confidence interval (CI). For continuous variables we planned to use means and standard deviations to calculate a mean difference (MD) with 95% CI; however no continuous variables were encountered. If we had found similar outcomes reported on different scales, we would have calculated the standardised mean difference (SMD). We would have reversed the direction of effect, when necessary, to ensure consistency across trials. If data to calculate RRs or MDs were not given, we would have utilised the most detailed numerical data available to calculate the actual numbers or means and standard deviations (for example test statistics, P values).
Unit of analysis issues
In simple parallel group designs, when participants are individually randomised, the primary analysis was per participant randomised. We analysed studies with multiple treatment groups by treating each pair of arms as a separate comparison, as appropriate.
We planned to undertake analysis of studies with non-standard designs, such as cross-over trials and cluster-randomised trials, as described in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011); however no such trials were included.
Dealing with missing data
We analysed data on an intention-to-treat basis, as far as possible, meaning that all participants were analysed in the groups to which they are randomised. We made attempts to obtain missing data from the original trialists. Where this was not possible, we reported the data as given in the studies. If trials had reported sufficient detail to calculate MDs but gave no information on associated standard deviations (SD), we would have assumed the outcome had an SD equal to the highest SD from other trials within the same analysis. We did not need to do this as meta-analysis was not performed.
Assessment of heterogeneity
We did not perform any assessment of heterogeneity as none of the pre-specified comparisons were addressed by more than one trial. We had intended to combine trials only if they were thought to be clinically similar. We would have assessed heterogeneity between studies by visual inspection of the plots of data, the Chi² test for heterogeneity and the I²statistic (Higgins 2011). We would have defined the thresholds for interpretation of the I² statistic according to the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011).
Assessment of reporting biases
In view of the difficulty of detecting and correcting for publication bias and other reporting biases, we aimed to minimise their potential impact by ensuring a comprehensive search for eligible studies and by being alert to duplication of data. We encountered no duplication of data as no comparison was investigated by more than one trial.
Data synthesis
We intended to combine trials if interventions were similar, based on clinical criteria; however we did not find more than one study addressing any pre-specified comparison. We would have conducted a meta-analysis with a fixed-effect model to combine trial data unless there had been evidence of heterogeneity across studies.
Subgroup analysis and investigation of heterogeneity
We intended to perform sub-group analysis in order to explore the impact of these sub-groups on the interventions. We selected the following sub-groups:
Different catheter materials
Catheter material is a key determinant of encrustation (and presumably blockage) and this is directly linked to the interval between replacements. Antimicrobial impregnation of the catheter or use of special low-friction catheters could impact the need for antibiotic prophylaxis or a lubricant.
Participants over 75 versus participants under 75
Elderly people have unique anatomical and functional changes, both local and systemic. Elderly individuals are more likely to have voiding dysfunction, altered lower urinary tract anatomy, comorbidities, impaired immune function and poor local hygiene. These could have an impact on antimicrobial policy, health-care setting for catheter change or use of an aseptic technique. The authors have chosen 75 years as a marker for the age at which these issues would likely be most relevant.
Sex: male versus female
Sex of the individual can influence the interventions under study. The unique anatomy of the female perineum makes women more prone to urinary infections but also renders catheter change technically easy. Men with gross prostatic enlargement could pose technical problems in catheter change demanding greater skill and a hospital setting.
Level of care: community/self-care versus residential/assisted living
The level of care such as community care, self care or an assisted facility could potentially have an impact on the policies chosen with regard to catheter change in people requiring long-term urinary catheters.
Condition requiring catheterisation
Non-neurological versus neurological reason for indwelling catheter
The underlying condition could have an impact on the chosen policy. For example catheter change in people with neurogenic lower urinary tract dysfunction could be associated with distinct challenges. People with neurogenic bladder on long-term indwelling catheters are usually clinically advised to receive intermittent catheterisation. Many of these people have poor hand function, quadriplegia or impaired cognition and these factors are more likely to be associated with poor local hygiene, impaired nutrition and immunity. Some people with neurogenic dysfunction might have elevated bladder pressures in the form of severe neurogenic detrusor overactivity or poor compliance with consequent risk to the upper urinary tracts. This could conceivably make them more prone to sepsis during urethral manipulations.
People with retention versus those with incontinence
People with incontinence requiring an indwelling catheter are more likely to have cognitive impairment, limited ambulation or neurological disease such as Parkinsonism or stroke; while those with intractable retention are more likely to be suffering from severe cardiovascular or pulmonary disease. All these can influence the interventions under study in unique ways. However, subgroup analysis could not be performed due to the lack of included trials.
Sensitivity analysis
We intended to conduct sensitivity analyses by including or excluding trials we judged as high risk of bias. We did not conduct sensitivity analyses because meta-analysis was not performed.
Quality of evidence
Primary and secondary outcomes, as defined above, were classified by the review authors as 'critical', 'important' or 'not important' for decision making from the patients' perspective (Gould 2010; Guyatt 2011a; Guyatt 2011b; Guyatt 2013a; Guyatt 2013b). The GRADE Working Group recommend including up to seven outcomes in a systematic review. In this systematic review, GRADE methodology was adopted for assessing the quality of the evidence for the following outcomes classified as critical:
• Symptomatic CAUTI as defined by trialists • Participant satisfaction • Condition-specific quality-of-life measures • Adverse effects (urinary tract trauma)
• Adverse effects (death)
• Formal economic analysis
R E S U L T S Description of studies
Results of the search
We screened a total of 1125 records, identified by the literature search, for this review. From these records, we considered 61 for full text screening, of which we deemed three were suitable for inclusion in this review (Cheung 2008; Firestein 2001; Priefer 1982) . The flow of literature through the assessment process is shown in the PRISMA flowchart (Figure 1) . 
Included studies
Cheung 2008 randomised 20 subjects (6 males, 14 females) in a Hong Kong community nursing service to either sterile water or conventional 0.05% chlorhexidine gluconate for periurethral cleansing prior to insertion of a replacement of long-term urinary catheter. Subjects were excluded if they had a symptomatic UTI at the time of the replacement, were on antibiotic treatment or if they had only been using a long-term catheter for less than one month. The mean age of the subjects was 78.4 (SD = 11.8) years, and 55% lived in a nursing home. Urine cultures were taken from participants at baseline and then 1, 7 and 14 days after catheter replacement. Reported outcomes were colonisation counts greater than 10 cfu/mL and incidence of symptomatic CAUTIs. Firestein 2001 randomised 70 subjects (21 males, 49 females) in a geriatric centre in Israel to receive either 1 g of intravenous meropenem 30 minutes before long-term catheter replacement or no antibiotic before replacement. Subjects were excluded if their urinary catheter had been in place for less than 4 weeks or if there had been antibiotic use within the 2-week period before enrolment. The mean age of the subjects was 79.3 (SD = 9.6) years. Urine cultures were taken from participants at baseline and then 3, 7, 14 and 28 days after catheter replacement. Reported outcomes were positive urine cultures, incidence of infection, incidence of bacteraemia and death. Priefer 1982 randomised 17 men in a USA veterans administration nursing home to catheter replacements either: only for obstruction and/or infection or monthly as well as when indicated by obstruction and/or infection. Subjects who required transfer to a hospital for acute problems unrelated to the urinary tract were excluded. The mean age of subjects was 77.1 (SD = 16.3) years in the control group and 83.4 (SD = 7.9) years in the intervention group. Participants were observed over a six-month period and the following outcomes were reported: total number of irrigations required; number of catheter changes per month required; incidence of symptomatic CAUTI over the six months.
Excluded studies
We have listed the excluded studies along with reasons for exclusion in the Characteristics of excluded studies table. The most common reason for excluding studies was that the intervention did not relate to replacing long-term catheters.
Risk of bias in included studies
Detailed results of the 'Risk of bias' assessment are provided in Figure 2 ; Figure 3 and judgement of individual domains are summarised below. 
Concealment of allocation
Methods of allocation concealment were inadequately described in all three trials and we judged them to be unclear (Cheung 2008; Firestein 2001; Priefer 1982) 
Blinding
Blinding of participants and personnel in two studies are not described and are assumed to be impossible due to the nature of the interventions (Firestein 2001; Priefer 1982) . Blinding participants in one study to their method of periurethral cleansing would be possible, but is not described and therefore assumed not to occur (Cheung 2008). Additionally, this study provides no information on blinding of personnel. We assumed the outcomes in these studies were reported by the same unblinded personnel administering the intervention and they are therefore also classed as high risk. Microbiological outcomes for the three studies are classed as low risk, as we assumed microbiologists analysing urine cultures to be blind to participants.
Incomplete outcome data
We judged two studies to be at low risk of bias (Cheung 2008; Priefer 1982) . We judged Firestein 2001 to be at high risk of bias for this domain.
Selective reporting
All three trials reported all outcomes intended to be investigated by the trial and have been classed as low risk. Priefer 1982 does not report microbiological outcome, but this was not possible as urine cultures were not taken during this trial. Firestein 2001 reports incidence of CAUTI in the two groups, but not number of CAUTIs per subject over the time period.
Other potential sources of bias
We classed two studies as high risk for other areas of bias. In one study, the participants were all male (Priefer 1982) . This was unavoidable due to the nature of the study setting and this could have an impact on the outcome and therefore it was judged to be high risk. There is also a wide age range in participants. In the other study, there is a calculation error, inconsistent data and a positive urine culture is not defined (Firestein 2001) . We tried to contact the author but did not receive any response. 
Effects of interventions
One interval versus another interval between catheter replacement
One small trial found that replacing the catheter monthly as well as when clinically indicated resulted in fewer symptomatic CAUTIs than replacing the catheter monthly (RR 0.35, 95% CI 0.13 to 0.95; very low quality evidence; Analysis 1.1) (Priefer 1982). However, when expressed as number of symptomatic CAUTIs per subject over the six months, there was no significant difference between the two interventions. Participants in the 'monthly as well as clinically indicated' group required more catheter replacements but fewer irrigations than those in the clinically indicated group. However, the trial was too small (hence under-powered) to be reliable.
Antibiotic prophylaxis versus no prophylaxis at the time of catheter replacement
One small trial found that there was no statistically significant difference in incidence of positive urine culture between giving 1 g of intravenous meropenem 30 minutes before catheter replacement and no antibiotic: (i) 3 days after replacement (RR 0.95, 95% CI 0.80 to 1.13); (ii) 7 days after replacement (RR 0. 
Replacing catheter versus other policy e.g. washouts
No trials were identified that addressed this comparison.
Replacing in home environment versus clinical environment
Clean versus aseptic technique for replacing catheter
Cleaning solution A versus cleaning solution B
There was also no statistically significant difference in incidence of symptomatic CAUTI up to 14 days after replacement (Analysis 3.1). However, the trial was too small (hence under-powered) to be reliable. One small trial found that there was no statistically significant difference in rates of asymptomatic bacteruria between conventional 0.05% chlorhexidine gluconate (CHG) or sterile water periurethral cleansing solutions (i) 0 days after replacement (RR not estimable; 95% CI not estimable), (ii) 7 days after replacement (RR 0.80, 95% CI 0.42 to 1.52), (iii) 14 days after replacement (RR 0.91, 95% CI 0.66 to 1.24; Analysis 3.2) (Cheung 2008).
Lubricant A versus lubricant B or no lubricant
Patient versus carer versus health professional performing the catheter replacement procedure
A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Antibiotics at time of replacement versus no antibiotics at time of replacement for replacing long-term indwelling urinary catheters in adults 
D I S C U S S I O N Summary of main results
We identified three trials eligible for inclusion in this review (Cheung 2008; Firestein 2001; Priefer 1982) . All the included trials were small and under-powered with inadequate reporting to permit judgement. There was insufficient evidence to indicate that there was a lower incidence of symptomatic UTI in people whose catheter was replaced both monthly and when clinically indicated (RR 0. 
Overall completeness and applicability of evidence
None of the trials addressed the following comparisons: (i) replacing catheter versus other policy e.g. washouts, (ii) replacing in home environment versus clinical environment, (iii) clean versus aseptic technique for replacing catheter, (iv) lubricant A versus lubricant B or no lubricant, and (v) patient versus carer versus health professional performing the catheter replacement procedure. As for the policies that have been studied in this review, there are several areas of incompleteness. Two out of three studies report rates of CAUTI, an important clinical outcome. However, all the trials were small and the results were imprecise. The trials did not report outcomes such as cost, participant satisfaction, quality of life and other adverse effects such as encrustation. If a policy can be shown to be favourable in relation to these additional outcomes, it would be more likely to be implemented in worldwide practice. Each trial only explored one alternative intervention in relation to the control. Therefore there is only data on one antibiotic, one cleaning solution and one replacement timing regime. Furthermore, sub-group analysis was not carried out in any of the trials. The settings of these studies represent likely settings where people with long-term catheters would undergo replacements: the community, a geriatric centre and a care home.
Quality of the evidence
We assessed the quality of the evidence by examining the methodology in the report of each included trial. Since the quality of effect estimates are influenced by our judgement of the quality of methodology, the standard of reporting in the included trials directly influences the size of the effect estimates. Only one trial gave any indication as to randomisation techniques (Cheung 2008) . The randomisation method is not described in any detail in the report, but we found details of it through a reference provided and there was sufficient information to award this study low risk for selection bias. None of the three included trials gave any information on blinding of participants to the intervention. Depending on the policy, blinding of participants to their intervention at the time of catheter replacement can be impossible, for example in the trial assessing different times of replacement (Priefer 1982) or giving an antibiotic (Firestein 2001). However, blinding of participants may have been possible for using different cleaning solutions but was not detailed in Cheung 2008. We scored all three trials as high risk for performance bias as, in addition to the lack of participant blinding, we found no descriptions of blinding of personnel in any of the trials. In regard to detection bias, the three trials do not describe accurately their methods of detecting outcomes. Therefore, we do not know if the personnel assessing these outcomes are the same as the personnel who administered the intervention. We have judged all three trials to be unclear in this domain. We only found one trial to have high risk of attrition bias: this was due to the unexplained dropouts in each arm of the study (Firestein 2001) . Priefer 1982 had no dropouts and Cheung 2008 describes dropouts in detail so we judged these studies to have low risk for attrition bias. One study has some calculation errors in its results as well as discrepancy between different areas of the report (Firestein 2001) . We tried to contact the authors of this study for clarification. While we have no clarification, this study has been classed as high risk for other bias. GRADE quality of evidence was very low for all the assessed outcomes.
Potential biases in the review process
We searched the relevant databases with no language restriction imposed. We acknowledge that these databases may not contain all the trials that could have potentially been included in this review.
Agreements and disagreements with other studies or reviews
Current guidelines on policies regarding long-term urinary catheters show considerable variation regarding this common clinical situation. Most of the available guidance comes from documents that do not specifically address policies with regard to uri-nary catheters but deal with conditions where long-term catheterisation might be necessary (Gould 2009; Grabe 2015; NICE Clinical Guideline CG97 2010; NICE Clinical Guideline CG139 2012; NICE Clinical Guideline CG148 2012; Saskatchewan Guidelines 2013) . Guidelines are often unclear as to whether the comments with regard to use of long-term catheters are more widely applicable.
Timing of replacement of catheters
Existing guidelines take one or more of five different approaches with regard to the replacement of long-term catheters: 1. Most guidelines recommend that catheters should be changed when there is either infection or obstruction (ANZUNS Guideline 2013; Gould 2009; NICE Clinical Guideline CG139 2012; Saskatchewan Guidelines 2013) . This is the approach taken by the CDC Guideline on Catheter Associated Urinary Tract Infections that makes a Category II recommendation (implying a weak recommendation) (Gould 2009).
2. In contrast the EAU guideline on Urinary Infections recommends that change should be scheduled in anticipation of obstruction presumably based on previous need for change (Grade B, not based on randomized controlled trials) (Grabe 2015). Such a patient-centric approach is also recommended by the NICE Guideline (NICE Clinical Guideline CG139 2012).
3. A third approach has been to recommend that catheter changes should additionally be guided by the manufacturer's instruction (ANZUNS Guideline 2013; NICE Clinical Guideline CG139 2012). Presumably this would imply usage for the maximum duration that the manufacturer allows.
4. A fourth approach has been taken by two guidelines that refer to specific durations. The UK Royal Cornwall Hospitals NHS Guidance recommends that catheters could be left in place for up to 12 weeks while recognising that this might not always be feasible (Royal Cornwall Hospitals NHS Trust 2015) .
5. In contrast the NICE Guideline on Urinary Incontinence in Neurological Disease states that recurrent block occurring before six weeks should be regarded as a red flag and one must reassess for secondary problems (NICE Clinical Guideline CG148 2012) . Clearly, catheters are ordinarily expected to remain in situ without change for a longer duration than that. The final approach is a conspicuous lack of any comment on this subject in a guideline where one would ordinarily have expected guidance (NICE Clinical Guideline CG97 2010) .
Cleaning and antibiotic policies while changing catheters
1. The UK Royal Cornwall Hospitals Guideline states that cleaning the meatus with saline is suitable since there is no evidence of benefit with antiseptic solutions but makes no mention regarding use of antibiotic prophylaxis during catheter change (Royal Cornwall Hospitals NHS Trust 2015).
The Guidelines for the Prevention and Treatment of Urinary Tract Infections (UTIs) in Continuing Care
Settings from the Canadian Saskatchewan Government recommends against the use of prophylaxis during catheter change (Saskatchewan Guidelines 2013).
3. Two different NICE Guidelines recommend selective use of antibiotics only in those individuals with a history of recurrent infection during catheter change or on occasions when there has been trauma during catheter change (NICE Clinical Guideline CG139 2012; NICE Clinical Guideline CG148 2012) .
4. The EAU Guideline on Urinary Infections recommends against screening for asymptomatic bacteriuria before catheter change (Level of evidence 4, based on expert opinion) (Grabe 2015) . The CDC Guideline makes a strong recommendation against the use of prophylactic antibiotics but it is unclear whether the guideline is referring to continued use of prophylaxis in people with on-going long-term catheters or whether this refers to prophylaxis only during catheter replacement (Gould 2009). The need for additional research on use of single dose antibiotic prophylaxis has also been noted (NICE Clinical Guideline CG139 2012) .
A U T H O R S ' C O N C L U S I O N S Implications for practice
There is insufficient evidence to support catheter replacement monthly as well as when clinically indicated compared to only when clinically indicated. Further research with a larger number of participants could turn an insignificant reduction in symptomatic CAUTIs in the monthly replacement group to a significant reduction. It is unclear which policy is more favourable economically, as performing monthly replacements in addition to replacements when clinically indicated incurs more replacements, but less irrigations. As these figures were also insignificant further research is needed, particularly including the need for treatment of any symptomatic CAUTI.
There is not enough evidence to suggest whether antibiotics should be used at catheter replacement in patients with long-term catheters. However, not all variants of this intervention or outcomes have been assessed.
There is not enough evidence to suggest whether sterile water is as effective as 0.05% CHG solution for periurethral cleansing between catheter replacements for reducing rates, and delaying onset, of bacteruria and symptomatic CAUTIs. However, other factors such as patient comfort remain unexplored. A formal economic analysis should be performed to determine whether this is a more cost-effective approach.
Implications for research
Randomised controlled trials with higher numbers of participants and of higher quality are required in order to make recommendations for changing policies for replacing long-term catheters. Further research into the areas studied by the trials featured in this review would help strengthen the evidence to support their conclusions. Different types of antibiotics, different cleaning solutions and different periods between replacements could also be studied in addition to the interventions described in this protocol where no trials were found. Future research should aim to explore additional outcomes to asymptomatic bacteruria and symptomatic CAUTI such as participant satisfaction and cost-effectiveness. A validated questionnaire should be developed for assessing participant satisfaction and quality of life measures in order to reduce heterogeneity across trials. It is also important to identify which of these outcomes not yet studied are most crucial to decision making regarding policies for replacing long-term catheters in order to guide future research. Sub-group analysis would give valuable data as to whether certain policies are more effective in sub-groups such as females or younger participants. We did not identify any long-term follow-up data. It is paramount that future trials report long-term follow-up data as this is also valuable evidence.
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